Asset Management

Here’s why Pfizer’s vaccine bombshell may kick off a ‘massive rotation’ to value stocks

The news of a Covid-19 vaccine could spur investors to pile back into so-called value stocks

Here’s why Pfizer’s vaccine bombshell may kick off a ‘massive rotation’ to value stocks
Photo: Matteo Rossetti//Getty Images

Some of the world's largest investors had already started to pile into some of the world's most unloved stocks in anticipation that a vaccine would help lift share prices.

News of a promising trial of a vaccine against Covid-19 is what value investors have been waiting for.

WSJ Logo